|
Desai, Amar; Webb, Bryan; Gerson, Stanton L (2014) CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells. Radiother Oncol 110:538-45
|
|
Qing, Yulan; Wang, Zhengqi; Bunting, Kevin D et al. (2014) Bcl2 overexpression rescues the hematopoietic stem cell defects in Ku70-deficient mice by restoration of quiescence. Blood 123:1002-11
|
|
Qing, Yulan; Lin, Yuan; Gerson, Stanton L (2012) An intrinsic BM hematopoietic niche occupancy defect of HSC in scid mice facilitates exogenous HSC engraftment. Blood 119:1768-71
|
|
Kisby, G E; Olivas, A; Park, T et al. (2009) DNA repair modulates the vulnerability of the developing brain to alkylating agents. DNA Repair (Amst) 8:400-12
|
|
Liu, Lili; Gerson, Stanton L (2006) Targeted modulation of MGMT: clinical implications. Clin Cancer Res 12:328-31
|
|
Vollweiler, J L; Zielske, S P; Reese, J S et al. (2003) Hematopoietic stem cell gene therapy: progress toward therapeutic targets. Bone Marrow Transplant 32:1-7
|
|
Reese, Jane S; Liu, Lili; Gerson, Stanton L (2003) Repopulating defect of mismatch repair-deficient hematopoietic stem cells. Blood 102:1626-33
|
|
Bowman, Janice E; Reese, Jane S; Lingas, Karen T et al. (2003) Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients. Mol Ther 8:42-50
|
|
Zhou, Hang; Liu, Lili; Lee, Keunmyoung et al. (2002) Lung tumorigenesis associated with erb-B-2 and erb-B-3 overexpression in human erb-B-3 transgenic mice is enhanced by methylnitrosourea. Oncogene 21:8732-40
|
|
Gerson, Stanton L (2002) Clinical relevance of MGMT in the treatment of cancer. J Clin Oncol 20:2388-99
|
Showing the most recent 10 out of 39 publications
